Nuciferine Inhibits TMEM16A in Dietary Adjuvant Therapy for Lung Cancer
Lung cancer is a malignant tumor with the highest morbidity and mortality rates. Food therapy is a common adjuvant treatment for lung cancer due to its safety and painlessness. Developing new functional food and exploring novel drug targets is important for lung cancer adjuvant therapy. This study c...
Saved in:
Published in | Journal of agricultural and food chemistry Vol. 70; no. 12; pp. 3687 - 3696 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Chemical Society
30.03.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Lung cancer is a malignant tumor with the highest morbidity and mortality rates. Food therapy is a common adjuvant treatment for lung cancer due to its safety and painlessness. Developing new functional food and exploring novel drug targets is important for lung cancer adjuvant therapy. This study confirmed that the active ingredient nuciferine of the lotus leaf was a novel TMEM16A inhibitor by whole-cell patch clamp experiments and site-directed mutagenesis experiments. CCK8 assay, colony formation assay, wound healing assay, and Annexin-V assay were combined to prove that nuciferine inhibited the proliferation and migration of lung cancer cells and promoted cancer cell apoptosis by targeting TMEM16A. Moreover, the combination of nuciferine and cisplatin significantly enhanced the anti-cancer effect of cisplatin. In addition, the signal transduction pathway of nuciferine regulating LA795 cell proliferation, migration, and apoptosis was confirmed by western blot experiments. In vivo experiments showed that nuciferine was a safe and effective natural anti-cancer product for lung cancer. Tissue section pathological detection and pharmacokinetic experiments verified that intragastric administration of nuciferine significantly enhanced the cancer therapy effect of cisplatin and counteracted the toxicity of high concentrations of cisplatin. Therefore, nuciferine is an ideal functional food for adjuvant lung cancer treatment. |
---|---|
AbstractList | Lung cancer is a malignant tumor with the highest morbidity and mortality rates. Food therapy is a common adjuvant treatment for lung cancer due to its safety and painlessness. Developing new functional food and exploring novel drug targets is important for lung cancer adjuvant therapy. This study confirmed that the active ingredient nuciferine of the lotus leaf was a novel TMEM16A inhibitor by whole-cell patch clamp experiments and site-directed mutagenesis experiments. CCK8 assay, colony formation assay, wound healing assay, and Annexin-V assay were combined to prove that nuciferine inhibited the proliferation and migration of lung cancer cells and promoted cancer cell apoptosis by targeting TMEM16A. Moreover, the combination of nuciferine and cisplatin significantly enhanced the anti-cancer effect of cisplatin. In addition, the signal transduction pathway of nuciferine regulating LA795 cell proliferation, migration, and apoptosis was confirmed by western blot experiments. In vivo experiments showed that nuciferine was a safe and effective natural anti-cancer product for lung cancer. Tissue section pathological detection and pharmacokinetic experiments verified that intragastric administration of nuciferine significantly enhanced the cancer therapy effect of cisplatin and counteracted the toxicity of high concentrations of cisplatin. Therefore, nuciferine is an ideal functional food for adjuvant lung cancer treatment. Lung cancer is a malignant tumor with the highest morbidity and mortality rates. Food therapy is a common adjuvant treatment for lung cancer due to its safety and painlessness. Developing new functional food and exploring novel drug targets is important for lung cancer adjuvant therapy. This study confirmed that the active ingredient nuciferine of the lotus leaf was a novel TMEM16A inhibitor by whole-cell patch clamp experiments and site-directed mutagenesis experiments. CCK8 assay, colony formation assay, wound healing assay, and Annexin-V assay were combined to prove that nuciferine inhibited the proliferation and migration of lung cancer cells and promoted cancer cell apoptosis by targeting TMEM16A. Moreover, the combination of nuciferine and cisplatin significantly enhanced the anti-cancer effect of cisplatin. In addition, the signal transduction pathway of nuciferine regulating LA795 cell proliferation, migration, and apoptosis was confirmed by western blot experiments. In vivo experiments showed that nuciferine was a safe and effective natural anti-cancer product for lung cancer. Tissue section pathological detection and pharmacokinetic experiments verified that intragastric administration of nuciferine significantly enhanced the cancer therapy effect of cisplatin and counteracted the toxicity of high concentrations of cisplatin. Therefore, nuciferine is an ideal functional food for adjuvant lung cancer treatment.Lung cancer is a malignant tumor with the highest morbidity and mortality rates. Food therapy is a common adjuvant treatment for lung cancer due to its safety and painlessness. Developing new functional food and exploring novel drug targets is important for lung cancer adjuvant therapy. This study confirmed that the active ingredient nuciferine of the lotus leaf was a novel TMEM16A inhibitor by whole-cell patch clamp experiments and site-directed mutagenesis experiments. CCK8 assay, colony formation assay, wound healing assay, and Annexin-V assay were combined to prove that nuciferine inhibited the proliferation and migration of lung cancer cells and promoted cancer cell apoptosis by targeting TMEM16A. Moreover, the combination of nuciferine and cisplatin significantly enhanced the anti-cancer effect of cisplatin. In addition, the signal transduction pathway of nuciferine regulating LA795 cell proliferation, migration, and apoptosis was confirmed by western blot experiments. In vivo experiments showed that nuciferine was a safe and effective natural anti-cancer product for lung cancer. Tissue section pathological detection and pharmacokinetic experiments verified that intragastric administration of nuciferine significantly enhanced the cancer therapy effect of cisplatin and counteracted the toxicity of high concentrations of cisplatin. Therefore, nuciferine is an ideal functional food for adjuvant lung cancer treatment. Lung cancer is a malignant tumor with the highest morbidity and mortality rates. Food therapy is a common adjuvant treatment for lung cancer due to its safety and painlessness. Developing new functional food and exploring novel drug targets is important for lung cancer adjuvant therapy. This study confirmed that the active ingredient nuciferine of the lotus leaf was a novel TMEM16A inhibitor by whole-cell patch clamp experiments and site-directed mutagenesis experiments. CCK8 assay, colony formation assay, wound healing assay, and Annexin-V assay were combined to prove that nuciferine inhibited the proliferation and migration of lung cancer cells and promoted cancer cell apoptosis by targeting TMEM16A. Moreover, the combination of nuciferine and cisplatin significantly enhanced the anti-cancer effect of cisplatin. In addition, the signal transduction pathway of nuciferine regulating LA795 cell proliferation, migration, and apoptosis was confirmed by western blot experiments. experiments showed that nuciferine was a safe and effective natural anti-cancer product for lung cancer. Tissue section pathological detection and pharmacokinetic experiments verified that intragastric administration of nuciferine significantly enhanced the cancer therapy effect of cisplatin and counteracted the toxicity of high concentrations of cisplatin. Therefore, nuciferine is an ideal functional food for adjuvant lung cancer treatment. |
Author | Bai, Xue An, Hailong Kang, Xianjiang Guo, Shuai Li, Shuting Liu, Xinyi |
AuthorAffiliation | School of Life Sciences Key Laboratory of Molecular Biophysics, Institute of Biophysics, School of Sciences |
AuthorAffiliation_xml | – name: Key Laboratory of Molecular Biophysics, Institute of Biophysics, School of Sciences – name: School of Life Sciences |
Author_xml | – sequence: 1 givenname: Xue surname: Bai fullname: Bai, Xue organization: School of Life Sciences – sequence: 2 givenname: Xinyi surname: Liu fullname: Liu, Xinyi organization: School of Life Sciences – sequence: 3 givenname: Shuting surname: Li fullname: Li, Shuting organization: School of Life Sciences – sequence: 4 givenname: Hailong surname: An fullname: An, Hailong organization: Key Laboratory of Molecular Biophysics, Institute of Biophysics, School of Sciences – sequence: 5 givenname: Xianjiang surname: Kang fullname: Kang, Xianjiang organization: School of Life Sciences – sequence: 6 givenname: Shuai orcidid: 0000-0002-5342-9666 surname: Guo fullname: Guo, Shuai email: guoshuai@hbu.edu.cn organization: School of Life Sciences |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35298888$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkb1PwzAQxS0Eoh-wMyGPDKT44jp2xqqUUqmFpcyR4zjUVeoUO0Hqf49LCwMSCC8n637vdPdeD53a2mqEroAMgMRwJ5UfrGWpBqCIoJydoC6wmEQMQJyiLglMJFgCHdTzfk0IEYyTc9ShLE5FeF00fWqVKbUzVuOZXZncNB4vF5MFJCNsLL43upFuh0fFun2XtsHLlXZyu8Nl7fC8ta94LK3S7gKdlbLy-vJY--jlYbIcP0bz5-lsPJpHkiasiRSNRcxpQXQaVpY0D_9USkaHJRdCx0oLxUHkrOQF45CwgqoCQMVFDsATTvvo5jB36-q3Vvsm2xivdFVJq-vWZ3EyFIITGIr_oBAsSdkevT6ibb7RRbZ1ZhOuzr58CgA5AMrV3jtdfiNAsn0UWYgi20eRHaMIkuSHRJlGNqa2jZOm-kt4exB-durW2WDo7_gHHUGbtQ |
CitedBy_id | crossref_primary_10_1016_j_jare_2023_11_003 crossref_primary_10_1016_j_cpan_2025_01_002 crossref_primary_10_1016_j_biopha_2022_113392 crossref_primary_10_1021_acs_jafc_3c06142 crossref_primary_10_1016_j_bmcl_2022_129034 crossref_primary_10_1016_j_ijbiomac_2024_134587 crossref_primary_10_3390_antiox13060714 crossref_primary_10_1038_s41598_024_57595_w crossref_primary_10_1021_acs_jafc_2c06723 crossref_primary_10_1016_j_intimp_2023_110914 crossref_primary_10_1080_07391102_2023_2272743 crossref_primary_10_1016_j_ijbiomac_2023_125128 crossref_primary_10_1016_j_lfs_2023_122034 crossref_primary_10_48130_MPB_2023_0020 crossref_primary_10_1016_j_jbc_2023_104780 crossref_primary_10_1016_j_phymed_2022_154536 crossref_primary_10_1021_acs_jafc_2c03009 crossref_primary_10_1021_acs_jafc_2c04817 crossref_primary_10_1186_s13046_022_02405_2 crossref_primary_10_1016_j_ijbiomac_2024_134057 crossref_primary_10_3390_ijms241914532 crossref_primary_10_1016_j_ijbiomac_2022_11_123 crossref_primary_10_3389_fphar_2023_1264324 crossref_primary_10_1142_S0192415X22500616 crossref_primary_10_1016_j_ijbiomac_2024_130618 crossref_primary_10_1016_j_prmcm_2022_100167 crossref_primary_10_1021_acs_jafc_4c04929 crossref_primary_10_1186_s12890_024_02860_x crossref_primary_10_1016_j_phrs_2023_106820 |
Cites_doi | 10.1371/journal.pone.0036197 10.1038/s41571-020-00432-6 10.1111/jipb.12606 10.1016/j.phrs.2020.104721 10.1016/s0140-6736(16)30958-8 10.1016/j.csbj.2020.03.015 10.1016/j.jconrel.2020.11.047 10.3389/fphar.2020.00858 10.1155/2017/1583185 10.3390/ijms222010930 10.3389/fphar.2020.00528 10.1007/s00232-021-00188-9 10.1016/j.cllc.2020.11.005 10.3233/cbm-161507 10.1007/s11655-015-2140-3 10.1001/jamaoncol.2015.2095 10.3389/fphar.2021.643489 10.1016/j.phrs.2019.104323 10.1038/nrclinonc.2017.30 10.1007/s00424-017-1934-x 10.4172/pharmaceutical-sciences.1000277 10.1016/j.bpj.2019.11.015 10.1002/jcp.27865 10.1038/s41572-019-0064-5 10.1002/jcp.27529 10.1007/s00384-020-03711-x 10.1016/j.bcp.2020.114062 10.1007/s10555-018-9744-y 10.2174/1871520620666200403144945 10.1038/nrd.2016.230 10.1002/fsn3.1165 10.1371/journal.pone.0063770 10.1007/s00217-010-1290-y 10.3390/molecules23102723 10.1136/bmj.m4087 10.1016/j.jchromb.2010.04.020 10.1016/j.suronc.2019.04.003 10.1016/j.jbc.2021.101016 10.1007/s00424-020-02434-w 10.1186/s40880-019-0402-8 10.3390/cancers13184499 |
ContentType | Journal Article |
Copyright | 2022 American Chemical Society |
Copyright_xml | – notice: 2022 American Chemical Society |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
DOI | 10.1021/acs.jafc.1c08375 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Agriculture |
EISSN | 1520-5118 |
EndPage | 3696 |
ExternalDocumentID | 35298888 10_1021_acs_jafc_1c08375 h85819233 |
Genre | Journal Article |
GroupedDBID | - 4.4 55A 5GY 5VS 7~N 85S AABXI ABFLS ABFRP ABMVS ABUCX ACGFS ACJ ACS AEESW AENEX AFEFF AGXLV AHGAQ ALMA_UNASSIGNED_HOLDINGS AQSVZ CS3 DU5 EBS ED F5P GGK GNL GX1 IH9 JG K2 LG6 P2P ROL TWZ UI2 VF5 VG9 W1F WH7 X --- -~X .K2 AAHBH AAYXX ABBLG ABJNI ABLBI ABQRX ACGFO ADHLV BAANH CITATION CUPRZ ED~ JG~ CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
ID | FETCH-LOGICAL-a365t-c328273d0e91c0a3b3289aa534f788e2ce8c718b5f7d57165d3cd11c2db117673 |
IEDL.DBID | ACS |
ISSN | 0021-8561 1520-5118 |
IngestDate | Thu Jul 10 18:21:14 EDT 2025 Fri Jul 11 00:10:44 EDT 2025 Thu Jan 02 22:55:30 EST 2025 Tue Jul 01 01:40:08 EDT 2025 Thu Apr 24 22:52:01 EDT 2025 Fri Apr 01 15:02:32 EDT 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | nuciferine lung cancer adjuvant therapy functional food TMEM16A |
Language | English |
License | https://doi.org/10.15223/policy-029 https://doi.org/10.15223/policy-037 https://doi.org/10.15223/policy-045 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a365t-c328273d0e91c0a3b3289aa534f788e2ce8c718b5f7d57165d3cd11c2db117673 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-5342-9666 |
PMID | 35298888 |
PQID | 2641000958 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2648870148 proquest_miscellaneous_2641000958 pubmed_primary_35298888 crossref_primary_10_1021_acs_jafc_1c08375 crossref_citationtrail_10_1021_acs_jafc_1c08375 acs_journals_10_1021_acs_jafc_1c08375 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-03-30 |
PublicationDateYYYYMMDD | 2022-03-30 |
PublicationDate_xml | – month: 03 year: 2022 text: 2022-03-30 day: 30 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of agricultural and food chemistry |
PublicationTitleAlternate | J. Agric. Food Chem |
PublicationYear | 2022 |
Publisher | American Chemical Society |
Publisher_xml | – name: American Chemical Society |
References | ref9/cit9 ref6/cit6 ref36/cit36 ref3/cit3 ref27/cit27 ref18/cit18 ref11/cit11 ref25/cit25 ref16/cit16 ref29/cit29 ref32/cit32 ref23/cit23 ref39/cit39 ref14/cit14 ref8/cit8 Huang B. T. (ref22/cit22) 2015; 34 ref5/cit5 ref31/cit31 ref2/cit2 ref34/cit34 ref37/cit37 ref28/cit28 ref40/cit40 ref20/cit20 ref17/cit17 ref10/cit10 ref26/cit26 ref35/cit35 ref19/cit19 ref21/cit21 ref12/cit12 ref15/cit15 ref42/cit42 ref41/cit41 ref13/cit13 ref33/cit33 ref4/cit4 ref30/cit30 ref1/cit1 ref24/cit24 ref38/cit38 ref7/cit7 |
References_xml | – ident: ref11/cit11 doi: 10.1371/journal.pone.0036197 – ident: ref1/cit1 doi: 10.1038/s41571-020-00432-6 – ident: ref35/cit35 doi: 10.1111/jipb.12606 – volume: 34 start-page: 2084 year: 2015 ident: ref22/cit22 publication-title: Lat. Am. J. Pharm. – ident: ref37/cit37 doi: 10.1016/j.phrs.2020.104721 – ident: ref6/cit6 doi: 10.1016/s0140-6736(16)30958-8 – ident: ref38/cit38 doi: 10.1016/j.csbj.2020.03.015 – ident: ref13/cit13 doi: 10.1016/j.jconrel.2020.11.047 – ident: ref21/cit21 doi: 10.3389/fphar.2020.00858 – ident: ref23/cit23 doi: 10.1155/2017/1583185 – ident: ref32/cit32 doi: 10.3390/ijms222010930 – ident: ref42/cit42 doi: 10.3389/fphar.2020.00528 – ident: ref26/cit26 doi: 10.1007/s00232-021-00188-9 – ident: ref2/cit2 doi: 10.1016/j.cllc.2020.11.005 – ident: ref10/cit10 doi: 10.3233/cbm-161507 – ident: ref41/cit41 doi: 10.1007/s11655-015-2140-3 – ident: ref9/cit9 doi: 10.1001/jamaoncol.2015.2095 – ident: ref25/cit25 doi: 10.3389/fphar.2021.643489 – ident: ref29/cit29 doi: 10.1016/j.phrs.2019.104323 – ident: ref4/cit4 doi: 10.1038/nrclinonc.2017.30 – ident: ref27/cit27 doi: 10.1007/s00424-017-1934-x – ident: ref17/cit17 doi: 10.4172/pharmaceutical-sciences.1000277 – ident: ref28/cit28 doi: 10.1016/j.bpj.2019.11.015 – ident: ref30/cit30 doi: 10.1002/jcp.27865 – ident: ref7/cit7 doi: 10.1038/s41572-019-0064-5 – ident: ref36/cit36 doi: 10.1002/jcp.27529 – ident: ref15/cit15 doi: 10.1007/s00384-020-03711-x – ident: ref31/cit31 doi: 10.1016/j.bcp.2020.114062 – ident: ref16/cit16 doi: 10.1007/s10555-018-9744-y – ident: ref5/cit5 doi: 10.2174/1871520620666200403144945 – ident: ref24/cit24 doi: 10.1038/nrd.2016.230 – ident: ref34/cit34 doi: 10.1002/fsn3.1165 – ident: ref19/cit19 doi: 10.1371/journal.pone.0063770 – ident: ref33/cit33 doi: 10.1007/s00217-010-1290-y – ident: ref18/cit18 doi: 10.3390/molecules23102723 – ident: ref3/cit3 doi: 10.1136/bmj.m4087 – ident: ref20/cit20 doi: 10.1016/j.jchromb.2010.04.020 – ident: ref12/cit12 doi: 10.1016/j.suronc.2019.04.003 – ident: ref39/cit39 doi: 10.1016/j.jbc.2021.101016 – ident: ref40/cit40 doi: 10.1007/s00424-020-02434-w – ident: ref8/cit8 doi: 10.1186/s40880-019-0402-8 – ident: ref14/cit14 doi: 10.3390/cancers13184499 |
SSID | ssj0008570 |
Score | 2.5151262 |
Snippet | Lung cancer is a malignant tumor with the highest morbidity and mortality rates. Food therapy is a common adjuvant treatment for lung cancer due to its safety... |
SourceID | proquest pubmed crossref acs |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 3687 |
SubjectTerms | active ingredients adjuvants antineoplastic activity apoptosis Aporphines - pharmacology Aporphines - therapeutic use Bioactive Constituents, Metabolites, and Functions cancer therapy Cell Proliferation cisplatin food chemistry functional foods Humans intragastric administration leaves lung neoplasms Lung Neoplasms - drug therapy Lung Neoplasms - genetics Lung Neoplasms - metabolism morbidity mortality neoplasm cells pharmacokinetics Signal Transduction site-directed mutagenesis toxicity Western blotting |
Title | Nuciferine Inhibits TMEM16A in Dietary Adjuvant Therapy for Lung Cancer |
URI | http://dx.doi.org/10.1021/acs.jafc.1c08375 https://www.ncbi.nlm.nih.gov/pubmed/35298888 https://www.proquest.com/docview/2641000958 https://www.proquest.com/docview/2648870148 |
Volume | 70 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3JTsMwELVYLnBgX8omI8GBQ0ptx1mOUaEsor3QSr1F3gIFFFCTHODrGSehiK0it0R2EttjzxvPzDNCR56iCciGcWRCueP6LndCJloOTwDOSSaI5jbfudvzLgfu9ZAPP2lyvnvwKTkVKms-iEQ1iQK44PNZNE-9wLeGVtS-nay6lqi9CucgTgCgoHZJ_vYGq4hU9lUR_YEuSy3TWa6OK8pKckIbXPLYLHLZVG8_qRv_0YAVtFSDTRxV0rGKZky6hhaju3FNuGHW0UWvUDa6BcAmvkrvR3KUZ7jfPe8SL8KjFJ-NTC7GrzjSDwWA7hz3KxoCDGAX38BKgdtWbsYbaNA577cvnfpwBUcwj-eOYmBs-Uy3TAj_JZiE-1AIztwErGJDlQkU6C3JE19zMKq4ZkoToqiWhPiezzbRXPqcmm2EQ5eEgtm9EcADigVSGigVMEG1xxLtNtAx9EFcT44sLv3elMTlQ-iYuO6YBjr9GJFY1Qzl9qCMpyk1TiY1Xip2jillDz8GOYYpZP0iIjXPRRYDJiQl1gymloHl2G6_NtBWJSGTLwKGDQO4dv7Zzl20QG0Shc1sbO2huXxcmH2ANrk8KGX6HWFs8GE |
linkProvider | American Chemical Society |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwzV1Jb9NAFH4q5VB6YC0Q1kFqDxycZmY8Xg4crHRJaJJLU6k3dzZDWuSi2BYq_4a_wi_jje0EgWjUSyV8szUznuXNe9-btwzAdqBZhrRhPZUx4fmhL7yYy54nMoRziktqhIt3Hk-CwYn_8VScrsGPRSwMdqLAloraiP87uwDddd_OZaa7VCNqCBd-lEf26htqacWH4R4u6Q5jB_vT_sBrLxLwJA9E6WmOikXITc_GWFtyhe-xlIL7GWqAlmkbaeTRSmShEahACMO1oVQzoygNg5Bju3fgLmIf5vS7pH-8ZPYuP3zjRUK9CLFIawn9V4-d_NPFn_LvGlBbC7eDB_BzOS21T8tFtypVV3__K2Pkfz1vD-F-C61J0uyFR7Bm88ewmXyat-lF7BM4nFTa-fIgtCbD_PNMzcqCTMf7YxokZJaTvZkt5fyKJOa8QhWjJNMm6QJBaE9GyBdJ3-2S-Rac3MpInsJ6fpnb50Bin8aSu5MgRD-aR0pZLBVxyUzAM-N3YAfnPG1ZQZHWVn5G0_ojLkTaLkQHdheEkOo2H7u7FuTLihrvlzW-NrlIVpR9t6CtFBmGswLJ3F5WRYoImNbIOlpZBoWPO2zuwLOGMJd_RMQeR_i8uOE438LGYDoepaPh5Ogl3GMufMTFdPZewXo5r-xrBHWlelNvKwJnt02PvwAqjlGP |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwzV1Lb9NAEB6VIiF64E0Jz0WiBw5Os7tePw4crKShoU2ERCr15u7LNC1yotgWKv-Hv8LvYtZ2IoEg4lIJ32ztrvcxM_vNzmMB3gSaZUgb1lMZE54f-sKLuex5IkM4p7ikRrh45_EkODzxP5yK0y34voqFwU4U2FJRG_EdVy9M1mYYoPvu-4XMdJdqRA7hypfyyF59RU2teDca4LLuMTY8mPYPvfYyAU_yQJSe5qhchNz0bIy1JVf4HkspuJ-hFmiZtpFGOa1EFhqBSoQwXBtKNTOK0jAIObZ7A246K6HT8ZL-p7XAdzniG08S6kWIR1pr6J967PZAXfy6B_4F2NYb3PAu_FhPTe3XctmtStXV337LGvnfz909uNNCbJI0PHEftmz-AHaSz8s2zYh9CO8nlXY-PQixySg_n6lZWZDp-GBMg4TMcjKY2VIur0hiLipUNUoybZIvEIT45BjlI-k7blk-gpNrGclj2M7nuX0CJPZpLLk7EUIUpHmklMVSEZfMBDwzfgf2cM7TViQUaW3tZzStP-JCpO1CdGB_RQypbvOyu-tBvmyo8XZdY9HkJNlQ9vWKvlIUHM4aJHM7r4oUkTCtEXa0sQxuQu7QuQO7DXGu_4jIPY7wefqP43wFtz4OhunxaHL0DG4zF0XiQjt7z2G7XFb2BWK7Ur2sOYvA2XWT4093zlQS |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nuciferine+Inhibits+TMEM16A+in+Dietary+Adjuvant+Therapy+for+Lung+Cancer&rft.jtitle=Journal+of+agricultural+and+food+chemistry&rft.au=Bai%2C+Xue&rft.au=Liu%2C+Xinyi&rft.au=Li%2C+Shuting&rft.au=An%2C+Hailong&rft.date=2022-03-30&rft.issn=1520-5118&rft.volume=70&rft.issue=12+p.3687-3696&rft.spage=3687&rft.epage=3696&rft_id=info:doi/10.1021%2Facs.jafc.1c08375&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-8561&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-8561&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-8561&client=summon |